As demonstrated by the schema in Figure 1, treatment with the EGFR-targeted NPs loaded with PTX and LON decreased tumor volume and decreased the expression of hypoxic and MDR associated proteins in the orthotopic breast cancer model. Here, EGFR is linked to neoplasm.